Hypogonadism: therapeutic risks, benefits, and outcomes
JT Sigalos, AW Pastuszak, M Khera - Medical Clinics, 2018 - medical.theclinics.com
Hypogonadism - Medical Clinics Skip to Main Content Medical Clinics Log in Register Log in
Subscribe Claim Skip menu theclinics.com theclinics.com External Link All Clinics External Link …
Subscribe Claim Skip menu theclinics.com theclinics.com External Link All Clinics External Link …
[引用][C] Hypogonadism: Therapeutic Risks, Benefits, and Outcomes
JT Sigalos, AW Pastuszak… - Medical clinics of North …, 2018 - dialnet.unirioja.es
Hypogonadism: Therapeutic Risks, Benefits, and Outcomes.
JT Sigalos, AW Pastuszak, M Khera - The Medical Clinics of North …, 2017 - europepmc.org
Hypogonadism is a common condition defined by the presence of low serum testosterone
levels and hypogonadal symptoms, and most commonly treated using testosterone therapy …
levels and hypogonadal symptoms, and most commonly treated using testosterone therapy …
Hypogonadism: Therapeutic Risks, Benefits, and Outcomes
JT Sigalos, AW Pastuszak… - The Medical clinics of …, 2018 - pubmed.ncbi.nlm.nih.gov
Hypogonadism is a common condition defined by the presence of low serum testosterone
levels and hypogonadal symptoms, and most commonly treated using testosterone therapy …
levels and hypogonadal symptoms, and most commonly treated using testosterone therapy …
Therapeutic Risks, Benefits, and Outcomes
JT Sigalos - Urology, An Issue of Medical Clinics of North …, 2018 - books.google.com
Therapeutic Risks, Benefits, and Outcomes Page 184 Hypogonadism Therapeutic Risks,
Benefits, and Outcomes John T. Sigalos, BA a, Alexander W. Pastuszak, MD, PhDb, c, Mohit …
Benefits, and Outcomes John T. Sigalos, BA a, Alexander W. Pastuszak, MD, PhDb, c, Mohit …